Recent evidence suggests that alterations in insulin/insulin-like growth factor 1 (IGF1) signaling (IIS) can increase mammalian life span. For example, in several mouse mutants, impairment of the growth hormone (GH)/IGF1 axis increases life span and also insulin sensitivity. However, the intracellular signaling route to altered mammalian aging remains unclear. We therefore measured the life span of mice lacking either insulin receptor substrate (IRS) 1 or 2, the major intracellular effectors of the IIS receptors. Our provisional results indicate that female Irs1 ؊/؊ mice are long-lived. Furthermore, they displayed resistance to a range of age-sensitive markers of aging including skin, bone, immune, and motor dysfunction. These improvements in health were seen despite mild, lifelong insulin resistance. Thus, enhanced insulin sensitivity is not a prerequisite for IIS mutant longevity. Irs1 ؊/؊ female mice also displayed normal anterior pituitary function, distinguishing them from long-lived somatotrophic axis mutants. In contrast, Irs2 ؊/؊ mice were short-lived, whereas Irs1 ؉/؊ and Irs2 ؉/؊ mice of both sexes showed normal life spans. Our results therefore suggest that IRS1 signaling is an evolutionarily conserved pathway regulating mammalian life span and may be a point of intervention for therapies with the potential to delay age-related processes. 
logical conditions with significant morbidity and mortality (1) . Although aging appears to be stochastic in nature, involving accumulation of molecular damage caused by processes such as oxidation or glycation, the rate of aging is also influenced by genetic variation (2) ; there are striking differences in longevity between animal species, and mutations in single genes can extend life span in laboratory animals (2) .
Although the mechanisms controlling the rate of aging in mammals remain poorly understood, there is growing evidence that the insulin/insulin-like growth factor (IGF) signaling (IIS) pathway is important (2, 3) . This pathway has long been known to play pleiotropic roles in the development, growth, reproduction, stress resistance, and metabolism of multicellular animals (3). More recently it has been found to regulate adult life span in the nematode worm Caenorhabditis elegans and the fruit fly Drosophila (2, 4, 5) . Evidence is mounting that it also does so in mice, in which heterozygote deletion of the Igf1 receptor (Igf1r) extends female life span by 25% (6) , although others have criticized this study for the short life span in the control animals (7, 8) . In addition, FIRKO mice, which lack the insulin receptor (Insr) in adipose tissue, display an 18% life span extension (9) , although the mechanisms of life span extension in this model are uncertain. Modulation of IIS may also be the mechanism by which life span is extended in Prop1 df , Pit1 dw , and Ghrhr lit mice and mice lacking the growth hormone (GH) receptor (10 -13) , all of which have reduced function of the somatotropic axis and markedly decreased plasma IGF1 levels, but these models have additional endocrine abnormalities.
In C. elegans and Drosophila, aging is controlled by activity of the insulin/IGF1 receptor, via the insulin receptor substrate (IRS)/phosphoinositide 3-hydroxy (PI3) kinase/forkhead transcription factor pathway (14, 15) . However, in mammals, the situation is far more complex owing to greater signaling diversity with distinct insulin and Igf1 receptors and multiple IRS proteins, PI3 kinase signaling components, and forkhead proteins (16) . Which of the postreceptor signaling molecules are the key regulators of life span remains unclear.
A further complication is that several mutations of IIS are clearly harmful. In C. elegans and Drosophila, certain mutations can result in developmental lethality, whereas others reduce adult life span, suggesting that moderate or specific alterations in pathway activity may be needed to extend life span (4) . Similarly, severe global reduction of IGF1R and INSR function in humans or mice or deletion of Insr in selected tissues in mice can result in perinatal lethality, severe insulin resistance and type II diabetes, hyperlipidemia, liver dysfunction, and obesity (17) (18) (19) (20) (21) (22) (23) . Thus, it seems likely that extension of the mammalian life span will only result from reductions of IIS of the right degree, involving the right intracellular signaling elements and in the right tissues (24) . Furthermore, in view of the adverse effects of some IIS mutations, it is important to determine whether extension of life span is accompanied by an improvement in health during aging, an issue not addressed in the two mouse studies of IIS and life span thus far reported (6, 9) .
Previously we have shown that deletion of chico, the single Drosophila IRS protein, extends life span by up to ϳ50% (4). To address the role of post-IIS receptor signaling in the regulation of mammal life span and age-related pathology, we therefore examined longevity in mice mutant for either Irs1 or Irs2, the two major mammalian IRS proteins, and subsequently assessed metabolism and measures of age-sensitive markers of aging.
MATERIALS AND METHODS

Reagents
All reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) unless stated otherwise.
Mouse models and husbandry
The generation and genotyping of Irs1 and Irs2 mutant mice have been described previously (25, 26) .
ϩ/Ϫ , Irs2 ϩ/Ϫ , and wild-type (WT) control littermate mice for each line were generated from heterozygote breeding pairs for either Irs1 or Irs2 strains (25, 26) . All mouse strains were maintained on a C57BL/6 background after 10 backcrosses.
Longevity study
Mice were maintained at ϳ22°C under a 12-h light/dark cycle (lights on from 7:00 AM-7:00 PM). Mice were housed in groups of three to eight same-sex littermates under specific pathogen-free conditions within individually ventilated cages (Techniplast UK Ltd, Kettering, Northamptonshire, UK). Mice were maintained in the same room for the duration of the study, and no additional animals were brought into this room; therefore, the colony was effectively kept under closed barrier conditions. Sentinel animals were screened every 3 months for pathogenic bacteria, viruses, and parasites, with all test results being negative throughout this study. Mice had ad libitum access to normal chow [2018 Teklad Global (5% fat, 18% protein, 57% carbohydrate, and 20% other components) Rodent Diet; Harlan Teklad, Bicester, Oxfordshire, UK] and water. Mice were monitored daily and weighed monthly, but otherwise were left undisturbed until they died naturally. If death appeared imminent, mice were weighed, examined for macroscopic pathological changes, and phenotypically assessed according to UK Home Office License Guidelines for animal welfare, and, if deemed necessary, individual mice were euthanized and this was considered the date of death. Of all the mice that died, 11% were euthanized, and the reminder died spontaneously. There were no significant differences in the proportions of each mode of death across the genotypes. When a sole surviving female mouse from each strain remained within a cage, this mouse was placed in an adjacent cage of female mice of the same strain. Sole surviving male mice within a cage were provided with a female companion not associated with this study. KaplanMeier survival curves were constructed using the known birth and death dates of each individual mouse, and the log-rank test was used to evaluate statistical differences between groups. Maximum life span was calculated as the mean age of the oldest 20% of mice from each genotype. Survival was assessed from a total of 81 female (46 
Metabolic studies and analysis of food intake
For phenotyping studies, two separate cohorts of female Irs1 Ϫ/Ϫ mice and control littermates were generated from the same breeding pairs used in the longevity studies but not included in the longevity analysis. These mice were studied at 450 and 700 days of age. Blood samples were collected from mice via tail vein bleeds or from cardiac puncture on terminally anesthetized mice. Blood glucose was measured using a Glucometer Elite (Bayer Corporation, Tarrytown, NY, USA). Glucose, insulin, and IGF1 tolerance tests were performed on mice as described previously (25, 26) . Fasting plasma insulin and leptin levels were determined with ELISAs (Linco Research, St. Charles, MO, USA) after an overnight fast. For food intake studies, mice were housed singly and allowed to acclimatize for 1 week before food intake was measured. Food intake and body mass were determined over 14 consecutive days. Resting metabolic rate (RMR) and core body temperature, measured using a rectal probe (Digitron Instrumentation Ltd., Torquay, Devon, UK), were determined as described previously (27) . Individual mice from these additional cohorts were killed at either 450 or 700 days of age for further hormonal, anatomical, and gene expression analyses.
Pituitary hormone and plasma IGF1 assays
Pituitary glands were dissected and homogenized in 1 ml of phosphate-buffered saline. Aliquots were taken for assay of GH, prolactin, luteinizing hormone (LH), and thyroid-stimulating hormone (TSH) using specific reagents kindly provided by Dr. A. L. Parlow and by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA (28) . For IGF1 assays, plasma samples were extracted with acid/alcohol for 30 min at room temperature and then centrifuged. IGF1 was measured by radioimmunoassay using rat IGF1 (Diagnostic Service Laboratories Inc., Webster, TX, USA) as standard and for Iodogen labeling and goat anti-rat IGF1 antibody (Diagnostic Service Laboratories Inc.).
Pancreatic immunocytochemistry and measurement of ␤-cell mass
Pancreases were removed, cleared of fat and lymph nodes, fixed in Bouin's solution, embedded in paraffin, and cut into 5-m sections. Insulin staining and morphometric analysis were performed as described previously (27) .
Real-time polymerase chain reaction (PCR)
Real-time PCR was performed as described previously using FAM/TAMRA primers from Applied Biosystems (Foster City, CA, USA) (27, 29) . Analysis was performed using the standard curve method with results expressed relative to Gapdh. We used a general linear model (GLM) to examine the effects of genotype, age, and presence/absence of a genotype ϫ age interaction for real time-PCR data. Primer sets used were
Sod2 Mm00449726_m1, and Tfam Mm00447485_m1.
Generation, normalization, and analysis of microarray data
For the liver mRNA extraction, samples from female Irs1 Ϫ/Ϫ mice and control littermates were homogenized on ice using a Positron homogenizer in TRIzol reagent (Invitrogen Ltd, Paisley, UK), followed by purification using RNeasy columns (http://www1.qiagen.com; Qiagen Ltd, Crawley, UK;). RNA quality and concentration were determined using an Agilent Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA). Changes in transcript abundance were measured using mouse whole genome oligonucleotide microarrays (Mouse Genome 430 2.0 Array; Affymetrix UK Ltd., High Wycombe, UK), with all protocols undertaken at the Institute of Child Health (ICH) Gene Microarray Centre, University College London (London, UK). A total of four biological replicates were used. The cRNA probe generation, washing, labeling, and scanning followed Affymetrix and ICH Gene Microarray Centre standard protocols. Raw image files were converted to probe-level data files (.cel files). Analysis of microarray data was limited to probesets with present transcripts (30) , and the data were normalized with GCRMA at the probe level (30) and loess at the probeset level using functions available in BioConductor in R (http://www. R-project.org) (31) . Cyber-T (32) was used to generate P values for identification of significantly differentially expressed probesets. All probesets were aligned to Ensembl genes (33) , and only unique probeset-to-gene alignments were used for further analysis. Functional annotation was taken from Ensembl (33) .
Identification of regulated pathways from microarray data
To identify Gene Ontology (GO) (34) terms and functional annotation based on Interpro protein domains (35), we used Catmap (36) on gene lists based on ranks of Cyber-T statistics. The method uses a Wilcoxon rank-sum test to identify regulated categories.
Measurement of T cell surface marker expression
Venous blood from mice of the indicated ages and genotypes was analyzed for the naive/memory CD4 and CD8 T cell subsets by flow cytometry using the following antibodies: CD4 (GK1.5; eBiosciences, London, UK) CD8␣ (53-6.6; BD PharMingen, Oxford, UK), CD44 (IM7; eBiosciences), and CD45RB (C363.16A; eBiosciences). Cells were acquired with a BD Biosciences LSR II instrument and analyzed using the FlowJo (Tree Star, Ashland, OR, USA) software package.
Computed tomography (CT) scanning
Formalin-fixed femurs were scanned using a Skyscan 1072 X-ray Microtomograph (SkyScan, Kontich, Belgium). Images were obtained with a rotation step of 0.67°between each image and were then reconstructed to give a stack of twodimensional images, using NRecon (version 1.4.4; SkyScan). Three-dimensional modeling and analysis were then performed using CTAn software (version 1.5.0.2; SkyScan). The following bone morphometric parameters were obtained: percent cancellous bone volume, trabecular number, and trabecular separation.
Rotarod assay
Mice were placed on the Rotarod (RotaRod type 7650; Ugo Basile, Comerio, Italy) as it was rotating at 20 rpm. After 100 s the rate of revolution was increased and reached a maximum of 36 rpm within 90 s. The length of time that each animal spent on the rod was measured, with a cutoff time of 5 min. The test was performed three times for each animal with at least 15 min between each test.
Statistical methods
All statistical analyses were performed with Minitab (version 13; Minitab Ltd., Coventry, UK) and GraphPad Prism (version 4; GraphPad, San Diego, CA, USA) software, using unpaired t test, one-way analysis of variance, or a GLM. Results are reported as means Ϯ se except where indicated. P Ͻ 0.05 was regarded as statistically significant.
RESULTS
Deletion of Irs1 but not Irs2 extends life span in mice
Log-rank testing was used to evaluate differences in life span in WT, heterozygote (ϩ/Ϫ), and null (Ϫ/Ϫ) Irs1 and Irs2 mice. By using the data for both sexes combined, median life span in Irs1 Ϫ/Ϫ mice was signifi-cantly increased by 140 days (from 760 to 900 days) or 18% relative to that of WT mice (log-rank test, 2 ϭ14.5, PϽ0.0001) ( Fig. S1 ; Tables S1 and S2 Tables S1 and S2 ). However, deletion of Irs1 in male mice had no significant effect on life span compared with that for WT or Irs1 ϩ/Ϫ mice (PϾ0.05, Fig. 1B ; Tables S1 and S2), possibly explained by the lower numbers of male Irs1 Ϫ/Ϫ mice used in this study. In both female and male Irs2 Ϫ/Ϫ mice, life span was significantly reduced compared with that for WT controls ( 2 ϭ14.1, PϽ0.001 and 2 ϭ43.1, PϽ0.0001 for females and males, respectively) ( Fig. 1C, D ; Tables S1  and S2 ). No change in life span was seen in either female or male mice heterozygous for either Irs1 or Irs2 compared with WT controls (Tables S1 and S2 ). In summary, deletion of Irs1 increased longevity in females but not in males, whereas homozygous deletion of Irs2 significantly shortened life span in females and particularly in males, consistent with the progressive and sexually dimorphic diabetic phenotype seen in this strain.
Long-lived female Irs1
؊/؊ mice show delayed age-sensitive markers of aging
Female Irs1
Ϫ/Ϫ mice appeared healthier than WT animals at older ages and had younger looking fur and skin. Dermatitis, often ulcerative, occurs in old C57BL/6 mice, and its incidence is significantly reduced by caloric restriction (CR) (37) . Our female Irs1 Ϫ/Ϫ mice were fully resistant to this pathological change, whereas WT mice showed rates similar to those seen previously (37) (Fig. 2A) . This difference was not apparent at younger ages, Ϫ/Ϫ mice. Percent cancellous bone volume (E), trabecular number (F), and trabecular separation (G) were determined (nϭ4 per genotype). Results are means Ϯ se. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001.
suggesting (Fig. 2B) . We also examined age-related changes in immune function, which include an increase in memory T cells and a reduction in naive T cells (38) . Such alterations have been shown to predict longevity phenotypes in mice (39) . At both 450 and 700 days of age, female Irs1 Ϫ/Ϫ mice had significantly fewer memory and more naive T cells, and these differences were more pronounced in the older cohort (Fig. 2C, D) . In C57BL/6 mice, cancellous bone volume decreases markedly between 6 wk and 2 yr of age (40) . Micro-CT scanning of femurs from 450-and 700-day-old animals demonstrated increased cancellous bone volume with increased trabecular numbers and reduced trabecular separation in female Irs1
Ϫ/Ϫ mice compared with WT mice (Fig.  2E-G) despite the observation that young Irs1 Ϫ/Ϫ mice have osteopenia (41) . Therefore, Irs1 Ϫ/Ϫ female mice showed improved health and delayed aging biomarkers compared with control animals at later ages across a range of indices.
We did not detect dermatitis in male Irs1 Ϫ/Ϫ mice [incidence of dermatitis: 7 of 35 (18%) in male WT and 0 of 10 (0%) in male Irs1 Ϫ/Ϫ mice]. Examination of T cell profiles in 450-day-old male Irs1 Ϫ/Ϫ mice revealed a reduced proportion of memory cells and increased numbers of naive cells compared with aged control animals (Fig. S1) . Therefore, although we did not demonstrate life span extension in male Irs1 Ϫ/Ϫ mice most likely due to the small numbers of mice studied, these animals also show delayed aging biomarkers.
؊/؊ mice have persistent insulin resistance with preserved ␤-cell mass Lowered fasting insulin and glucose levels have been reported during CR and in Prop1 df , Pit1 dw , Ghrhr lit , and GH receptor null mice (7, 8, 42) . FIRKO mice also display both reduced insulin levels and resistance to age-related loss of glucose homeostasis (9) . These findings suggest that improved insulin sensitivity might extend life span in these animals. Young (80-day-old) female C57BL/6 Irs1 Ϫ/Ϫ mice displayed normal fasting glucose levels, mildly impaired glucose tolerance, and mild hyperinsulinemia (data not shown), consistent with our previous studies on a mixed 129Sv/C57BL/6 background (25, 26) . Between 450 and 700 days, there was deterioration in glucose homeostasis in WT but not in Irs1 Ϫ/Ϫ mice (Fig. 3A-C) . Irs1 Ϫ/Ϫ mice at 450 days of age were hyperinsulinemic and were insulin resistant, as shown by insulin tolerance testing (Fig. 3D, E) . In 700-day-old Irs1 Ϫ/Ϫ mice, insulin levels remained mildly elevated and increased ␤-cell mass was maintained compared with that in control mice, consistent with lifelong insulin resistance (Fig. 3D F) . These data demonstrate that improved insulin sensitivity is not a requirement for increased life span in IIS mutants.
؊/؊ mice do not have a pituitary endocrine phenotype
Irs1
Ϫ/Ϫ mice, like long-lived pituitary dwarf mice, show reduced body mass (Fig. 4A) . However, levels of pituitary GH, TSH, LH, and prolactin in female Irs1 Ϫ/Ϫ mice did not differ from those of controls at any age ( Fig. 4B; Fig. S2 ; data not shown); thus, unlike pituitary dwarf mice, these mice show no pituitary endocrine defects (7). In the pituitary dwarf mice and GH receptor null mice, reduced GH levels or action results in IGF1 deficiency (7) . In contrast, and consistent with the preservation of GH function, circulating total IGF1 levels in female Irs1 Ϫ/Ϫ mice were the same as those in WT mice at all ages (Fig. 4C) . However, glucose clearance in response to IGF1 in 450-day-old female Irs1 Ϫ/Ϫ mice was impaired, indicating IGF1 resistance (Fig. 4D) 
Female Irs1
؊/؊ mice are not calorically restricted but have reduced fat mass
CR extends life span in a range of organisms (42). Daily food intake was not reduced in female Irs1
Ϫ/Ϫ mice and, in fact, when adjusted for body weight, exceeded that of controls by 30% (Fig. 4E, F) . However, by using a GLM with food intake as the dependent variable, genotype as a fixed factor, and body mass as a covariate no significant effect of genotype on food intake was observed (GLM, genotype effect: F ϭ 1.555, P ϭ 0.226; body mass effect: F ϭ 0.567, P ϭ 0.459). Although CR in mammals reduces core body temperature, rectal core body temperature was slightly elevated in female Irs1 Ϫ/Ϫ mice and significantly elevated at 450 days of age (Fig. 4G) . However, indirect calorimetry revealed that at 450 and 700 days of age, mass-adjusted RMR was the same as that in female Irs1 Ϫ/Ϫ mice and WT animals (Fig. S1 ). Together, these findings imply that altered pituitary function, IGF1 levels, food intake, reduced core body temperature (43), and energy expenditure do not underlie the longevity phenotype in female Irs1 Ϫ/Ϫ mice. However, like mice under CR, Irs1 Ϫ/Ϫ mice displayed reduced fat mass throughout life (Fig. 4H ). Relative to body weight, this reduction in fat mass was nonsignificant in 450-day-old animals but became significant at 700 days (Fig. 4I ). This lower adiposity was reflected in reduced plasma leptin levels at both ages (Fig. S2) .
Differential gene expression in the livers of female
Irs1
؊/؊ and WT mice
To further explore possible mechanisms underlying the increased life span in Irs1 Ϫ/Ϫ female mice, we undertook candidate mRNA expression analysis using liver tissue to permit comparison with similar data generated from other long-lived mutant mice and from mice under CR. In female Irs1 Ϫ/Ϫ and WT mice at 80, 450, and 700 days of age, there was evidence of alterations in expression of genes involved in oxidative stress, detoxification, DNA repair, and the response to genotoxic stress. An age-dependent reduction in catalase (Cat) expression was seen in WT mice by 700 days of age, whereas expression did not decline in female Irs1 Ϫ/Ϫ mice (Fig. S3) . Expression of glutathione Stransferase a4 (Gsta4) was elevated in young Irs1 Ϫ/Ϫ mice and declined with age in animals of both genotypes (Fig. S3) . Expression of excision repair crosscomplementing rodent repair deficiency complementation group 8 (Ercc8), the Cockayne syndrome type A gene product, was elevated at all ages in Irs1 Ϫ/Ϫ mice (Fig. S3) . A similar trend in expression values was seen with growth arrest and DNA damage inducible, ␤ (Gadd45b) with the Irs1 Ϫ/Ϫ mice showing increased expression (Fig. S3) . In contrast, there were no significant differences in mRNA levels for Foxo1, Igfbp2, Irs2, PBEF1/visfatin, Pgc1a, Sirt1, Nox4, Sod2, Cyp2d22, Gnmt, Cdkn2a, Mat1a, Hspb1, or Nrf1 (data not shown).
We then compared gene expression in the livers of female Irs1 Ϫ/Ϫ and WT mice at 80 and 450 days of age using whole genome oligonucleotide arrays. Expression values, biologically annotated using GO and Interpro, were analyzed using Catmap (36) to identify alterations, at the level of biochemical and cellular processes, between the two genotypes at both ages. The majority of the common up-regulated gene classes were associated with energy metabolism including GO categories carbohydrate metabolism, oxidative phosphorylation, and tricarboxylic acid cycle ( Table 1) . The Interpro classes flavin-containing monooxygenases 1 and 5 were up-regulated (Table 1) . GO categories down-regulated in 80-and 450-day-old female Irs1 Ϫ/Ϫ mice included immune response and the related antigen processing and serine esterase activity (Table 1) .
DISCUSSION
Our findings provide new insights into the specific intracellular signaling pathways that mediate the effects of IIS on life span in mammals. Our data suggest that deletion of Irs1 but not Irs2 extends life span in female mice. Taken together with data from other long-lived mouse models, these findings are consistent with longevity control via an endocrine-signaling axis involving 
IGF1, IGF1R, and IRS1. Male and female Irs2
Ϫ/Ϫ mice are short-lived because of their diabetic phenotype and neither mice heterozygote for Irs1, consistent with the preliminary observations of others (44) , nor for Irs2 show increased life span. Thus, IRS1 and IRS2 are likely to be differentially coupled to upstream and downstream signaling elements with IRS1 acting in different tissues and cell types and on different downstream regulated genes to control longevity.
Our studies also show for the first time that specific manipulation of IIS signaling components results in resistance to a number of age-related biomarkers. Female Irs1 Ϫ/Ϫ mice displayed better motor control, coordination, and balance than wild-type mice at 450 days of age, as demonstrated by improved performance in the Rotarod test. Aging also leads to a progressive deterioration in immune function in both mice and humans (45) . In humans, immune senescence poten- Ϫ/Ϫ and WT mice (nϭ12 per genotype; PϽ0.01 at all data points between WT and Irs1 Ϫ/Ϫ mice). B) GH levels at 450 and 700 days of age in female WT and Irs1 Ϫ/Ϫ mice (nϭ4 -6 per genotype). C) Serum total IGF1 levels at 450 and 700 days of age in female WT and Irs1 Ϫ/Ϫ mice (nϭ4 -6 per genotype). D) IGF1 tolerance tests in 450-day-old female WT and Irs1 Ϫ/Ϫ mice (nϭ6 per genotype). E) Food intake in 450-day-old female WT and Irs1 Ϫ/Ϫ mice (nϭ12 per genotype). F) Food intake per gram of body weight in 450-day-old WT and Irs1 Ϫ/Ϫ mice (nϭ12 per genotype). G) Rectal core body temperature in 450 and 700-day-old female WT and Irs1 Ϫ/Ϫ mice (nϭ5-8 per genotype). H) Total fat mass at 450 and 700 days of age in female WT and Irs1 Ϫ/Ϫ mice (nϭ4 -6 per genotype). I) Fat mass per gram of body weight in 450-and 700-day-old female WT and Irs1 Ϫ/Ϫ mice (nϭ4 -6 per genotype). For all panels results are means Ϯ se. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001; N.S., not significant. tially leads to an increased risk of infection in the elderly population (45) . T cell subset analysis in female Irs1 Ϫ/Ϫ mice revealed a reduced proportion of memory cells and increased numbers of naive cells compared to those in aged control animals. These results also support the view that T cell subsets can provide robust biomarkers of aging (38) . In addition, female Irs1 Ϫ/Ϫ mice were completely resistant to age-related dermatitis, a condition that has been shown to affect C57BL/6 mice and is thought to be due to inflammation (37) . Thus, it is possible that resistance to age-related increases in inflammatory processes protects against aging in Irs1 Ϫ/Ϫ mice as age-related increases in inflammation appear to contribute to human aging (46) . Bone loss with advancing age is a major underlying cause of osteoporotic fractures in elderly humans. Female Irs1 Ϫ/Ϫ mice were more resistant than control animals to the age-related decline in bone mass despite Significantly up: or down-regulated functional categories (GO and Interpro) with significance determined using Catmap. *P Ͻ 0.01; **P Ͻ 0.001; ***P Ͻ 0.0001. MHC ϭ major histocompatability complex.
reports that IRS1 is required for normal bone growth in young mice (41) . Therefore, female Irs1 Ϫ/Ϫ mice were resistant to a number of age-related changes associated with neurological and neuromuscular, immune, skin, and bone diseases.
Our studies also give insights into the potential mechanisms by which alteration of IIS regulates longevity. Although Irs1 Ϫ/Ϫ mice displayed reduced adiposity, which is also a feature of CR and FIRKO mice, our findings show that increased longevity can be uncoupled from improvements in insulin sensitivity associated with reduced fat mass. Therefore, although Irs1
Ϫ/Ϫ mice, like CR and FIRKO mice, did not develop an age-related deterioration in glucose homeostasis, in these animals this lack of deterioration was due to ␤-cell compensation in the face of lifelong insulin resistance rather than increased insulin sensitivity. Consistent with these findings, longlived C. elegans and Drosophila IIS mutants and pituitary dwarf mice accumulate fat as they age, although in the latter case, this accumulation may reflect reduced lipolytic effects of GH and/or increased insulin sensitivity (2) . Moreover, if leptin-deficient ob Ϫ/Ϫ mutant mice are subjected to CR, they remain fat (48% body fat) yet show the same extension of life span as ob ϩ/ϩ mice subjected to CR (14% body fat) (47). These observations suggest that, rather than absolute fat mass, alterations in the endocrine function of fat may be key to the regulation of longevity. This hypothesis is also supported by the findings that enhanced FOXO function in adipose tissue in C. elegans and Drosophila increases longevity (2) . The beneficial effects of short-term CR on metabolic parameters and muscle glucose metabolism are, in fact, preserved in Irs1 Ϫ/Ϫ mice, further suggesting dissociation between the effects of CR and Irs1 deletion (48) . An additional observation of relevance to the interaction between insulin resistance and extended life span is the finding that overexpression of the putative hormone Klotho in mice extends life span and concomitantly impairs insulin action (44) . In contrast, deletion of Klotho results in a phenotype suggestive of accelerated aging (49) . However, although potentially providing further evidence that life span can be extended in the face of insulin resistance, the situation is complicated by the findings that Klotho also has significant interactions with FGF23 and calcium metabolism (50) . Mice lacking FGF23 display an accelerated aging phenotype and hypoglycemia, and, therefore, current evidence suggests that Klotho is unlikely to extend life span purely by inhibiting insulin action (50) .
Female Irs1 Ϫ/Ϫ mice have a reduced body size, but, unlike the long-lived pituitary hormone-deficient dwarf strains and GH receptor null mice, pituitary hormone levels are preserved. In addition, GH and thyroxine replacement in Pit1 dw mice increases body size and induces puberty while preserving the long-lived phenotype (51) . These findings suggest that the thyroxine, prolactin, and GH deficiencies seen in Prop1
and Ghrhr lit dwarf strains may not be the sole contributor to life span extension. However, although direct comparisons remain to be formally undertaken, the absolute life span extension seen in Prop1 df , Pit1 dw , and Ghrhr lit dwarf strains is greater than that seen in the pure IIS mutants, suggesting that IRS1-independent but GH/thyroxine-dependent effects may play a distinct role in regulating longevity. Female Irs1 Ϫ/Ϫ mice also had normal RMR and a mildly elevated core temperature at 450 days of age and were not calorie restricted. Together these findings suggest that reduced food intake and altered metabolic parameters are not required for life span extension in female Irs1 Ϫ/Ϫ mice. In addition, the observed life span extension was apparent only in female but not in male Irs1 Ϫ/Ϫ mice. This result is consistent with the findings that in dInR and chico mutant flies and in Igf1r ϩ/Ϫ mice life span extension is predominantly seen in female animals (2, 4 -6) . The basis of this sexually dimorphic phenotype is not clear, but it does provide further evidence that the mechanisms underlying life span extension in IIS mutants do not completely overlap with those of the pituitary dwarf mice and mice under CR, for which life span is increased in both sexes. However, because of the smaller numbers of male Irs1 Ϫ/Ϫ mice studied, we cannot formally exclude a modest increase in life span in these animals, and, indeed, we detected alterations in two age-sensitive markers of aging in these animals.
To further understand the mechanisms of life span extension in female Irs1 Ϫ/Ϫ mice we undertook both candidate gene expression analysis and whole genome microarray studies on livers from female Irs1 Ϫ/Ϫ and WT animals. Such data are currently available for some of the pituitary dwarf strains but not for Igf1r ϩ/Ϫ and FIRKO mice. Young Irs1 Ϫ/Ϫ mice show increased expression of the glutathione S-transferase Gsta4, which detoxifies the lipid peroxidation product 4-hydroxynonenal (4HNE). Glutathione S-transferase isoforms active against 4HNE are also up-regulated in long-lived daf-2 mutant worms, chico ϩ/Ϫ flies, and Prop1 df and Ghrhr lit mice (52, 53 ; unpublished data). Catalase expression was also modestly increased, consistent with observations in Prop1 df mice (54) . Thus, elements of antioxidant and detoxification defense are up-regulated in Irs1 Ϫ/Ϫ mice. Ercc8 expression was increased at all ages in female Irs1 Ϫ/Ϫ mice. Mutations in Ercc8 cause Cockayne syndrome type A, a segmental progeroid syndrome in which patients develop signs of aging and age-related pathological changes at an early age (55). Short-lived mice with compound mutations in the Cockayne syndrome type B gene and Xpd (DNA excision repair protein ERCC-2) paradoxically show suppression of the somatotropic axis, suggesting a complex interplay between IIS and DNA repair mechanisms (56) .
Our analysis of liver microarrays encompassed identification of cellular and biochemical processes differentially expressed between female Irs1 Ϫ/Ϫ and control mice at both 80 and 450 days of age. This approach demonstrated increased expression of genes involved in energy metabolism and, in particular, mitochondrial genes across a number of categories. Similar changes have been found in the livers of long-lived Prop1 df and Ghrhr lit mice and during acute and long-term CR (53, 57, 58) , suggesting that altered mitochondrial metabolism may be important during life span extension. Mice selected for increased metabolic efficiency have been reported to be long-lived (59) . Immune response, antigen processing, and serine esterase categories were reduced in female Irs1 Ϫ/Ϫ mice, consistent with the immune changes seen in these animals and the evidence for reduced inflammation. Down-regulation in humoral defense and inflammatory response-related transcripts have been described previously in the livers of Ames and Little mice (53) and during long-term CR (60) . These gene expression results suggest some commonality in the underlying mechanisms in female Irs1 Ϫ/Ϫ mice and other long-lived mouse models.
In conclusion, our findings provisionally suggest that a reduction in IRS1-dependent signaling is an evolutionarily conserved mechanism of mammalian life span regulation. Critically, the observed increased in life span in female Irs1 Ϫ/Ϫ mice is accompanied y maintenance of youthful characteristics and a reduction in age-sensitive markers of aging. Taken together with the data from lower organisms and other mouse models, IRS1 and the processes that it regulates may be points of intervention for therapies with the potential to delay age-related processes in humans.
